CHRISTOPHER RAZONABLE: Open Payments
NPI 1881365559 · KAILUA, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$475 in 20 payments from 7 companies in 2025. Trend: 2023 $171 · 2024 $320 · 2025 $475
Food & beverage: $475
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $222 |
| ABBVIE INC. | 4 | $94 |
| Lundbeck LLC | 2 | $63 |
| Gilead Sciences, Inc. | 1 | $35 |
| GlaxoSmithKline, LLC. | 1 | $25 |
| PFIZER INC. | 1 | $23 |
| Novo Nordisk Inc | 1 | $14 |
Products named: AIRSUPRA, BREZTRI, REXULTI, UBRELVY, VRAYLAR, SHINGRIX, PAXLOVID, QULIPTA.
Industry payments across HI — which companies pay providers there.
